The A2aR adenosine receptor controls cytokine production in iNKT cells
Open Access
- 3 March 2010
- journal article
- highlights
- Published by Wiley in European Journal of Immunology
- Vol. 40 (3), 682-687
- https://doi.org/10.1002/eji.200939897
Abstract
The purine nucleoside adenosine is an important anti‐inflammatory molecule, inhibiting a variety of immune cells by adenosine receptor‐mediated mechanisms. Invariant NKT (iNKT) cells recognize glycolipids presented on CD1d molecules and produce vigorous amounts of cytokines upon activation, hence regulating immune reactions. The mechanisms polarizing their cytokine pattern are elusive. Previous studies demonstrated that adenosine can suppress IFN‐γ production by iNKT cells. We describe the expression of all four known adenosine receptors A1R, A2aR, A2bR and A3R on mouse iNKT cells. We show that IL‐4 production in primary mouse iNKT cells and a human iNKT line is efficiently inhibited by A2aR blockade with an inverse relation to IL‐4. These data are supported by A2aR‐deficient mice, which exhibit largely decreased levels of IL‐4, IL‐10 and TGF‐β concomitantly with an increase of IFN‐γ upon α‐galactosylceramide administration in vivo. While A2aR inhibits other lymphocyte populations, A2aR is required for the secretion of IL‐4 and IL‐10 by iNKT cells. These data suggest adenosine:A2aR‐mediated mechanisms can control the cytokine secretion pattern of iNKT cells.Keywords
This publication has 28 references indexed in Scilit:
- Langerhans Cell Maturation and Contact Hypersensitivity Are Impaired in Aryl Hydrocarbon Receptor-Null MiceThe Journal of Immunology, 2009
- The A2B Adenosine Receptor Impairs the Maturation and Immunogenicity of Dendritic CellsThe Journal of Immunology, 2009
- Diverse cytokine production by NKT cell subsets and identification of an IL-17–producing CD4 − NK1.1 − NKT cell populationProceedings of the National Academy of Sciences of the United States of America, 2008
- Adenosine A2Areceptor activation inhibits T helper 1 and T helper 2 cell development and effector functionThe FASEB Journal, 2008
- Selective activation, expansion, and monitoring of human iNKT cells with a monoclonal antibody specific for the TCR α‐chain CDR3 loopEuropean Journal of Immunology, 2008
- Natural killer T cell dysfunction in CD39-null mice protects against concanavalin A-induced hepatitisHepatology, 2008
- A2A receptors in inflammation and injury: lessons learned from transgenic animalsJournal of Leukocyte Biology, 2007
- Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppressionThe Journal of Experimental Medicine, 2007
- Adenosine A2A receptor activation reduces hepatic ischemia reperfusion injury by inhibiting CD1d-dependent NKT cell activationThe Journal of Experimental Medicine, 2006
- A2A adenosine receptor protects tumors from antitumor T cellsProceedings of the National Academy of Sciences of the United States of America, 2006